Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cholesterol
Pharma
FDA approves an oral PCSK9 med for 1st time in Merck's Lipfendra
The FDA has approved Merck's cholesterol-lowering daily pill Lipfendra. The PCSK9 inhibitor has been cleared for adults with hypercholesterolemia.
Kevin Dunleavy
Jul 16, 2026 9:30am
Merck bats for heart disease awareness
Apr 30, 2026 9:30am
FDA endorses LIB's convenient cholesterol-lowering PCSK9 drug
Dec 15, 2025 11:33am
Merck, St. Louis Cardinals pitch heart disease awareness push
Sep 17, 2025 4:58pm
Amgen tackles dangers of LDL cholesterol in 1st documentary film
Jul 9, 2025 7:55am
Family Heart Foundation, Amgen team up for new campaign
Oct 1, 2024 9:50am
